Phathom Pharmaceuticals, Inc. (PHAT) quarterly income statement — complete revenue, gross profit & net income history
Phathom Pharmaceuticals, Inc. (PHAT) annual income statement — 8-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 84.72M | 74.27M | 58.3M | 57.58M | 49.5M | 39.5M | 28.52M | 29.66M | 16.35M | 7.32M | 1.91M | 682K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 71.14% | 88.02% | 104.43% | 94.12% | 202.74% | 439.36% | 1391.58% | 4249.56% | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 18.37M | 15.1M | 12M | 7.65M | 6.19M | 5.04M | 3.72M | 3.81M | 2.36M | 1.38M | 426K | 352K | 121K | 123K | 0 | 168K | 175K | 149K | 128K | 135K |
| COGS % of Revenue | 21.68% | 20.32% | 20.58% | 13.28% | 12.5% | 12.75% | 13.06% | 12.86% | 14.41% | 18.79% | 22.28% | 51.61% | - | - | - | - | - | - | - | - |
| Gross Profit | 66.36M | 59.18M | 46.3M | 49.94M | 43.31M | 34.47M | 24.8M | 25.85M | 14M | 5.95M | 1.49M | 330K | -121K | -123K | 0 | -168K | -175K | -149K | -128K | -135K |
| Gross Margin % | 78.32% | 79.68% | 79.42% | 86.72% | 87.5% | 87.25% | 86.94% | 87.14% | 85.59% | 81.21% | 77.72% | 48.39% | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 53.2% | 71.7% | 86.75% | 93.18% | 209.47% | 479.44% | 1568.57% | 7733.03% | 11666.94% | 4935.77% | - | 296.43% | 30.86% | 17.45% | 100% | -24.44% | -34.62% | -13.74% | -2.4% | - |
| Operating Expenses | 66.44M | 63.14M | 61.78M | 55.86M | 58.59M | 94.39M | 103.66M | 85.27M | 84.79M | 83.25M | 71.44M | 70.2M | 35.54M | 31.7M | 30.08M | 46.47M | 42.35M | 45.36M | 37.78M | 33.04M |
| OpEx % of Revenue | 78.42% | 85.01% | 105.97% | 97.01% | 118.34% | 238.94% | 363.47% | 287.44% | 518.54% | 1136.65% | 3736.4% | 10293.84% | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 57.7M | 55.33M | 54.01M | 48.37M | 51.56M | 85.31M | 94.47M | 76.68M | 76.1M | 75.87M | 62.01M | 56.81M | 23.27M | 18.94M | 18.6M | 30.53M | 23.33M | 26.55M | 20.12M | 19.49M |
| SG&A % of Revenue | 68.1% | 74.49% | 92.64% | 84% | 104.15% | 215.97% | 331.27% | 258.51% | 465.38% | 1035.94% | 3243.2% | 8330.06% | - | - | - | - | - | - | - | - |
| Research & Development | 8.74M | 7.81M | 7.77M | 7.49M | 7.03M | 9.08M | 9.18M | 8.58M | 8.69M | 7.38M | 9.43M | 13.39M | 12.26M | 12.76M | 11.48M | 15.95M | 19.02M | 18.82M | 17.66M | 13.55M |
| R&D % of Revenue | 10.32% | 10.52% | 13.33% | 13.01% | 14.19% | 22.98% | 32.2% | 28.93% | 53.16% | 100.71% | 493.2% | 1963.78% | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 0 | 0 | 0 | -2K | 0 | -17K |
| Operating Income | -85K | -3.96M | -15.48M | -5.93M | -15.27M | -59.92M | -78.86M | -59.42M | -70.8M | -77.3M | -69.95M | -69.87M | -35.66M | -31.7M | -30.08M | -46.64M | -42.53M | -45.36M | -37.91M | -33.04M |
| Operating Margin % | -0.1% | -5.34% | -26.55% | -10.29% | -30.85% | -151.69% | -276.53% | -200.3% | -432.95% | -1055.43% | -3658.68% | -10245.45% | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 99.44% | 93.38% | 80.37% | 90.02% | 78.43% | 22.48% | -12.74% | 14.97% | -98.54% | -143.84% | -132.58% | -49.81% | 16.15% | 30.12% | 20.65% | -41.17% | -28.34% | -28.44% | -12.87% | 36.99% |
| EBITDA | 35K | -3.85M | -15.37M | -5.8M | -15.12M | -59.75M | -78.69M | -59.22M | -70.61M | -77.1M | -69.74M | -69.69M | -35.54M | -31.58M | -29.93M | -46.47M | -42.35M | -45.21M | -37.78M | -32.91M |
| EBITDA Margin % | 0.04% | -5.18% | -26.36% | -10.07% | -30.53% | -151.26% | -275.91% | -199.65% | -431.78% | -1052.74% | -3647.49% | -10218.33% | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 100.23% | 93.55% | 80.47% | 90.21% | 78.59% | 22.5% | -12.83% | 15.02% | -98.67% | -144.17% | -133% | -49.95% | 16.09% | 30.16% | 20.77% | -41.24% | -28.32% | -28.49% | -12.91% | 37.12% |
| D&A (Non-Cash Add-back) | 120K | 114K | 110K | 128K | 156K | 172K | 177K | 193K | 191K | 197K | 214K | 185K | 121K | 123K | 146K | 168K | 175K | 149K | 128K | 135K |
| EBIT | 1.49M | -2.48M | -14.57M | -4.73M | -13.87M | -58.29M | -76.25M | -55.86M | -67.09M | -73.68M | -65.68M | -66.54M | -33.14M | -31.35M | -28.6M | -45.45M | -41.81M | -45.25M | -37.91M | -33.05M |
| Net Interest Income | -13.79M | -13.59M | -14.06M | -15.21M | -14.7M | -15.73M | -15.43M | -15.08M | -14.77M | -14.14M | -12.86M | -9.68M | -7.39M | -9.27M | -7.76M | -8.31M | -8.55M | -5.55M | -2.75M | -2.77M |
| Interest Income | 1.6M | 1.51M | 1.74M | 1.2M | 1.41M | 1.79M | 2.64M | 3.51M | 3.71M | 3.62M | 4.31M | 3.35M | 2.72M | 348K | 1.46M | 1.29M | 726K | 112K | 7K | 6K |
| Interest Expense | 15.39M | 15.1M | 15.8M | 16.42M | 16.11M | 17.52M | 18.07M | 18.59M | 18.48M | 17.76M | 17.17M | 13.03M | 10.11M | 9.62M | 9.22M | 9.6M | 9.28M | 5.67M | 2.76M | 2.77M |
| Other Income/Expense | -13.81M | -13.62M | -14.89M | -15.22M | -14.7M | -15.89M | -15.45M | -15.03M | -14.78M | -14.15M | -12.9M | -9.7M | -7.58M | -9.26M | -7.74M | -8.4M | -8.56M | -5.56M | -2.76M | -2.79M |
| Pretax Income | -13.9M | -17.58M | -30.37M | -21.15M | -29.97M | -75.81M | -94.32M | -74.45M | -85.58M | -91.45M | -82.85M | -79.57M | -43.24M | -40.97M | -37.81M | -55.05M | -51.09M | -50.92M | -40.66M | -35.83M |
| Pretax Margin % | -16.4% | -23.67% | -52.09% | -36.73% | -60.55% | -191.91% | -330.71% | -250.98% | -523.34% | -1248.58% | -4333.26% | -11667.01% | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -13.9M | -17.58M | -30.37M | -21.15M | -29.97M | -75.81M | -94.32M | -74.45M | -85.58M | -91.45M | -82.85M | -79.57M | -43.24M | -40.97M | -37.81M | -55.05M | -51.09M | -50.92M | -40.66M | -35.83M |
| Net Margin % | -16.4% | -23.67% | -52.09% | -36.73% | -60.55% | -191.91% | -330.71% | -250.98% | -523.34% | -1248.58% | -4333.26% | -11667.01% | - | - | - | - | - | - | - | - |
| Net Income Growth % | 53.63% | 76.81% | 67.8% | 71.59% | 64.98% | 17.1% | -13.84% | 6.43% | -97.9% | -123.23% | -119.1% | -44.55% | 15.36% | 19.55% | 7.01% | -53.65% | -39.36% | -39.31% | -16.71% | 33.31% |
| Net Income (Continuing) | -13.9M | -17.58M | -30.37M | -21.15M | -29.97M | -75.81M | -94.32M | -74.45M | -85.58M | -91.45M | -82.85M | -79.57M | -43.24M | -40.97M | -37.81M | -55.05M | -51.09M | -50.92M | -40.66M | -35.83M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.16 | -0.21 | -0.37 | -0.29 | -0.41 | -1.05 | -1.31 | -1.05 | -1.32 | -1.56 | -1.42 | -1.39 | -0.76 | -0.84 | -0.89 | -1.54 | -1.54 | -1.33 | -1.14 | -0.95 |
| EPS Growth % | 60.98% | 80% | 71.76% | 72.38% | 68.94% | 32.69% | 7.75% | 24.46% | -73.68% | -85.71% | -59.55% | 9.74% | 50.65% | 36.84% | 21.93% | -62.11% | -57.14% | -33% | -18.75% | 39.87% |
| EPS (Basic) | -0.16 | -0.21 | -0.37 | -0.29 | -0.41 | -1.05 | -1.31 | -1.05 | -1.32 | -1.56 | -1.42 | -1.39 | -0.76 | -0.84 | -0.89 | -1.54 | -1.54 | -1.33 | -1.14 | -0.95 |
| Diluted Shares Outstanding | 84.89M | 83.75M | 82.05M | 73.82M | 73.4M | 72.47M | 71.97M | 71.05M | 64.63M | 58.56M | 58.37M | 57.29M | 56.78M | 48.5M | 42.35M | 41.31M | 38.82M | 38.27M | 38.04M | 37.76M |
| Basic Shares Outstanding | 84.89M | 83.75M | 82.05M | 73.82M | 73.4M | 72.47M | 71.97M | 71.05M | 64.63M | 58.56M | 58.37M | 57.29M | 56.78M | 48.5M | 42.35M | 41.31M | 38.82M | 38.27M | 38.04M | 37.76M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |